Smith & Nephew plc Declares Dividend of $0.14 (LON:SN)

Smith & Nephew plc (LON:SN) announced a dividend on Thursday, August 1st, Upcoming.Co.Uk reports. Stockholders of record on Thursday, October 3rd will be paid a dividend of $0.14 per share on Friday, November 8th. This represents a dividend yield of 1%. The ex-dividend date of this dividend is Thursday, October 3rd. The official announcement can be viewed at this link.

Smith & Nephew Price Performance

Shares of Smith & Nephew stock opened at GBX 1,123 ($14.45) on Thursday. The firm has a market cap of £9.82 billion, a PE ratio of 4,679.17, a price-to-earnings-growth ratio of 0.49 and a beta of 0.51. Smith & Nephew has a 12-month low of GBX 887 ($11.41) and a 12-month high of GBX 1,269 ($16.32). The company has a quick ratio of 0.84, a current ratio of 1.77 and a debt-to-equity ratio of 59.11. The company’s fifty day simple moving average is GBX 1,030.09 and its two-hundred day simple moving average is GBX 1,039.54.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Royal Bank of Canada reissued an “outperform” rating and issued a GBX 1,500 ($19.30) price target on shares of Smith & Nephew in a report on Tuesday, May 7th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 1,250 ($16.08) target price on shares of Smith & Nephew in a research report on Friday, May 3rd. Berenberg Bank reaffirmed a “hold” rating and issued a GBX 1,450 ($18.65) target price on shares of Smith & Nephew in a research report on Tuesday, July 16th. Finally, JPMorgan Chase & Co. raised their target price on shares of Smith & Nephew from GBX 1,300 ($16.72) to GBX 1,381 ($17.76) and gave the stock an “overweight” rating in a research report on Thursday, May 2nd. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 1,346.20 ($17.32).

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.